Work

Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Who Have Undergone Prior Allogeneic Stem Cell Transplant

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.4697.4697

Authors: Steven Coutre, Susan O'Brien, John C. Byrd, Peter Hillmen, Jennifer R. Brown, Martin JS Dyer, Anthony R. Mato, David B. Miklos, Michael Keating, Cathy Zhou, Maria Fardis, Lori Styles, Samantha Jaglowski

Institutions: Stanford Medicine, Stanford University, The University of Texas MD Anderson Cancer Center, The Ohio State University Wexner Medical Center, Leeds Teaching Hospitals NHS Trust, Dana-Farber Cancer Institute, University of Leicester, Hackensack University Medical Center, Pharmacyclics (United States), The Ohio State University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2558323997

FWCI: 1.834

Cites:

Cited by: 14

Related to: 10